Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GSK-1521498 reduces hedonistic eating behavior in overweight/obese subjects

Aug. 2, 2010

New DPP-4 inhibitors described by Indian researchers

July 30, 2010

Bionovo moves Menerba to phase III testing in Europe

July 30, 2010

FDA approves two new dose strengths of niacin/simvastatin

July 29, 2010

Generex Oral-lyn advances in phase III trial in diabetes type 1

July 29, 2010

DRL-17822 displays safety and potent activity in preclinical and clinical settings

July 29, 2010

Fumagillin reduces body weight and regulates fat metabolism in vivo

July 29, 2010

VRS-859 improves glycemic control in preclinical studies

July 28, 2010

U.S. researchers present new PKR1/PKR2 receptor antagonists

July 27, 2010

Clinical phase III data presented on linagliptin in type 2 diabetes

July 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...